Taproot Management’s Abbott ABT Stock Holding History

Taproot Management’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-70,425	Closed	-$7.23M	–	5
2026 Q1	$7.23M	Buy	+70,425	New	+$7.95M	1.37%	10

Other funds holding ABT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Taproot Management's ABT Position: Q2 2026 in Review

Taproot Management sold out of Abbott (ABT) in Q2 2026, closing a stake of 70,425 shares — an estimated $7.23M sold.

Taproot Management first reported a position in ABT in Q1 2026 and held it in 1 quarter. The position peaked at $7.23M in Q1 2026. 2,961 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

Taproot Management reported no remaining Abbott position as of Q2 2026 after selling out during the quarter.
Taproot Management sold 70,425 Abbott shares in Q2 2026, an estimated $7.23M.
Taproot Management first reported a position in Abbott in Q1 2026 and held it in 1 quarter.
Taproot Management's Abbott position peaked at $7.23M in Q1 2026.
2,961 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Taproot Management's 13F filing for Q2 2026.